Researchers inch closer to treatment for type of ovarian cancer

Patients with recurrent low-grade serous ovarian cancer had an 86 percent reduction in tumor size in a new study led by Verastem Oncology, according to a May 25 news release. 

Read the full post at Becker's Hospital Review - Healthcare News